PT-141
Safety Considerations
PT-141 is generally well tolerated, though side effects can include facial flushing, headache, nausea, and increased blood pressure in some users. These are usually dose-dependent and mild. Nasal spray versions tend to have more systemic side effects compared to subcutaneous injection. It is not recommended for individuals with uncontrolled hypertension, heart disease, or those taking dopamine agonists without clinician oversight. Cyclical or event-based use is typically recommended to avoid receptor fatigue.
Molecule / Formula
C50H68N14O10
PT-141 10mg/5mL DOSING
10 units low dose
15 units moderate dose
20-25 units typical dose
Start low, acclimate, titrate up based on how you feel
What Is the PT-141
PT-141, also known as Bremelanotide, is asynthetic peptide derived from Melanotan II, originally developed to stimulate melanin production. However, during early studies, researchers noticed a powerful secondary effect—increased sexual arousal. PT-141 was isolated to focus exclusively on these effects, without impacting skin pigmentation. It is now FDA-approved for hypoactive sexual desire disorder (HSDD) in premenopausal women and is widely used off-label for men as a libido-enhancing and erectile support compound. Unlike PDE5 inhibitors like Viagra or Cialis, PT-141 acts on the brain, not the vascular system, making it a fundamentally different type of sexual health therapy.
How It Works
PT-141 binds to melanocortin receptors, specifically MC3R and MC4R in the central nervous system—receptors deeply involved in regulating sexual behavior, arousal, and reward processing. These receptors are concentrated in the hypothalamus, the region of the brain responsible for instinctive and hormonal drives. Once bound, PT-141 enhances sexual desire by increasing dopamine release and activating neural circuits tied to arousal, motivation, and pleasure. In men, this can lead to spontaneous erections—even in the absence of visual or physical stimulation. In women, it boosts desire, sensitivity, and overall sexual satisfaction. Because it acts centrally rather than peripherally, it works even in individuals with psychological or neurochemical barriers to sexual function.
Benefits
PT-141 is used for both therapeutic andenhancement purposes. Benefits include:
Increased libido and sexual desire in men and women
Improved erectile function not reliant on blood flow mechanics
Heightened arousal and sensitivity during intimacy
Effective in cases of sexual dysfunction not responsive to Viagra or Cialis
No impact on blood pressure, making it safer for some cardiac patients v
Synergistic with PDE5 inhibitors, when desired Effects are typically felt within 30–60 minutes, peaking around 3 hours and lasting up to 12 hours.
Some users report next-day mood and connection benefits, attributed to oxytocin and dopamine interaction.